北陆药业：股东询价转让定价为8.09元/股

Core Viewpoint - Beilu Pharmaceutical (300016) has announced the preliminary pricing for its inquiry transfer at 8.09 yuan per share, based on the inquiry subscription situation as of July 3, 2025 [1] Group 1 - A total of 12 institutional investors participated in the inquiry transfer, with a combined effective subscription of 10.63 million shares, resulting in an effective subscription multiple of 1.44 times [1] - The shares intended for transfer have been fully subscribed, with the preliminary determination of the transferees being 11 institutional investors, who will collectively acquire a total of 7.3783 million shares [1]